A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.

• Status: Completed
• Trial end date: 1969-12-31

Summary

To provide trimetrexate glucuronate to immunosuppressed patients with Pneumocystis carinii pneumonia (PCP) for whom this investigational compound could provide significant medical benefit.

• Phase: N/A

Details

• Lead Sponsor: U.S. Bioscience
• Treatments: Calcium; Leucovorin; Levoleucovorin; Trimetrexate